Searchable abstracts of presentations at key conferences in endocrinology

ea0066p19 | Diabetes 1 | BSPED2019

Diasend download data and relation to diabetes control in a tertiary clinic cohort

Muniu Susan , Biss Chloe , Krone Ruth E , Barret Tim , Pemberton John , Drummond Lesley , Kershaw Melanie

Our large tertiary hospital-based diabetes service high HbA1c policy selects Children and Young People (CYP) with HbA1c above 64 mmol/mol for additional support. Two-week average blood glucose (ABG) is utilised in the high HbA1c clinic as a proxy for HbA1c and CYP are encouraged to reduce their 2 week ABG as a primary goal.Aims: To determine the relationship between HbA1c, 2 week and 3 month ABG and standard deviation (S.D.) in CYP with Ty...

ea0066in1.1 | (1) | BSPED2019

Cheetham Tim

Tim Cheetham is a University Reader and Honorary Consultant Paediatrician based in Newcastle-upon-Tyne, England, UK. He was appointed in 1996 following paediatric / endocrine / diabetes training in Oxford and Cambridge – and following 6 months as a neonatal consultant at Addenbrooke’s. He has a broad range of interests and has a key role in a number of clinical trials and studies in the field of clinical endocrinology including Graves’ disease, longer term outco...

ea0019s31 | Polycystic ovarian syndrome (PCOS): when does it start, why and what to do about it? | SFEBES2009

Evolution of obesity and insulin resistance: relevance to PCOS

Barrett Tim

Polycystic ovarian syndrome (PCOS) is one of the commonest endocrine disorders of young women, and the commonest cause of reduced fertility in this age group. There are fundamental metabolic disturbances integral to the syndrome that lead to significant cardiovascular risk, and these include obesity, insulin resistance, beta cell dysfunction, impaired glucose tolerance and type 2 diabetes, dyslipidemia, hypertension, obstructive sleep apnoea, a pro-coagulant state, and endothe...

ea0095p121 | Gonadal, DSD and Reproduction 2 | BSPED2023

Characterising puberty in children and young people with Alstrom Syndrome

Anwunah Ijeoma , Barrett Tim , Kershaw Melanie

Background: Alstrom syndrome (AS) is a very rare multisystem disorder secondary to mutations in the ALMS1 gene, associated with infantile cardiomyopathy, retinal dystrophy, early onset obesity, and diabetes. Whilst a previous international review, including 35 males, cited pubertal delay and hypogonadism to be common, no detailed characterisation of puberty exists. This retrospective longitudinal analysis aims to describe puberty in boys with AS.<p class="...

ea0077ecs1.2 | Broadening your Career Pathway - What else can you do with your skills? | SFEBES2021

Research Facilitation or Management

Giles Tim

There are many opportunities for those who pursue a career in science. This can include a direct route through academia and ultimately becoming a professor and leading your own research group. However, very few people go all the way through with this and therefore it is important to consider other options. Further career paths could include working in industry, government or in a research support setting amongst others. A career in research support is a rewarding one, often be...

ea0051cme4 | CME Training Day Abstracts | BSPED2017

Thyrotoxicosis – diagnosis and management

Cheetham Tim

Key discussion points• Make sure you know what it is that you are treating – is this Graves’ hyperthyroidism (with associated TSH receptor antibodies) or simply a brief, hyperthyroid phase of autoimmune thyroid disease (without TSH receptor antibodies) that will settle down spontaneously?• Ideally obtain the result of the thyroid receptor antibody titre pre intervention with carbimazole.&#...

ea0085dmd1.3 | Diabetes Symposium 4 | BSPED2022

Developing an early stage treatment for diabetic retinopathy

Curtis Tim

Diabetic retinopathy is a serious complication of diabetes that can lead to vision loss and blindness. With the prevalence of diabetes rising in children, the number of young people at risk of developing diabetic retinopathy is expected to increase in the coming years. Current treatments for diabetic retinopathy only target the end-stages of the disease when significant retinal damage has already occurred. Thus, there remains an unmet medical need for new treatments, particula...

ea0085dmd1.3 | Diabetes Symposium 5 | BSPED2022

Developing an early stage treatment for diabetic retinopathy

Curtis Tim

Diabetic retinopathy is a serious complication of diabetes that can lead to vision loss and blindness. With the prevalence of diabetes rising in children, the number of young people at risk of developing diabetic retinopathy is expected to increase in the coming years. Current treatments for diabetic retinopathy only target the end-stages of the disease when significant retinal damage has already occurred. Thus, there remains an unmet medical need for new treatments, particula...

ea0086cmw1.3 | Endocrine disease in pregnancy: pitfalls in testing and challenges in management; before, during and after | SFEBES2022

Hyperthyroidism

Korevaar Tim

In this presentation I will discuss various aspects of hyperthyroidism during pregnancy. First of all, I will discuss that the epidemiology points towards a physiological underlying cause but I will also exhibit the differential diagnoses that should be addressed. Second, I will discuss preconception and gestational management of Graves’ disease, specifically focusing on new concepts regarding antithyroid drug choice, cessation and options in case of antithyroid drug fai...